Scholar Rock Stock Surges

This is a news story, published by Yahoo Finance, that relates primarily to SRRK news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Biotech stock Scholar Rock

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest best biotech companies news, approvals Scholar Rock news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Scholar Rock Holding Stock

The Motley Fool

•

Health

Why Scholar Rock Holding Stock Topped the Market Today

Summary

Nutrition label

68% Informative

Scholar Rock (NASDAQ: SRRK ) was popular among investors on Wednesday after a positive new analyst note on the company made the rounds.

This resulted in the stock bumping nearly 3% higher on the day .

Its lead drug candidate -- apitegromab, a medicine that preserves muscle mass in patients with two types of spinal muscular atrophy ( SMA ), is under review for approval.

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful